Simulations Plus Slashes Guidance Amid Biotech Spending Cuts, Analyst Expresses Doubt

Simulations Plus Inc SLP stock tanked after the company lowered its fiscal 2025 sales outlook.The company expects third-quarter sales of $19 million-$20 million, much below the consensus of $22.78 million.On Wednesday, the company cut its 2025 sales forecast to $76 million—$80 million versus a consensus of $90.26 million, down from prior guidance of $90 million—$93 million.Also Read: What's Going On With Charles River, Certara, Simulations Plus Stocks On Friday?"Market uncertainties surrounding future fundi ...